DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
17.83 13.97 11.23 13.37

+8 more quarters

P/S ratio
1.03 0.75 0.62 0.72
P/FCF ratio
8.01 6.12 5.56 6.36
P/Operating CF
29.41 32.28 15.60 11.38
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.75 1.47 1.33 1.43
EV/EBITDA
8.62 7.25 6.57 6.93
EV/Operating CF
11.15 10.02 9.61 10.06
EV/FCF
13.59 12.00 11.94 12.65
Quick Ratio
1.36 1.31 1.19 1.26
Current Ratio
1.47 1.42 1.29 1.36
Net Debt/EBITDA
13.45 15.10 12.96 13.87
Debt/Assets
61.08% 61.22% 59.91% 58.68%
Debt/Equity
(22.44) (22.49) (28.02) (33.86)
Asset Turnover
0.80 0.80 0.78 0.76
Operating CF/Net income
1.85 1.62 2.31 5.60
Capex/Depreciation
(1.01) (0.55) (0.77) (0.88)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
11.91% 12.35% 13.05% 12.12%
Intangible Assets out of Total Assets
0.44 0.45 0.44 0.44
Share Based Compensation of Revenue
0.73% 0.82% 1.06% 1.14%
Graham Net Nets
(0.97) (1.34) (1.64) (1.44)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
5.61% 7.16% 8.91% 7.48%
Free Cash Flow Yield
12.48% 16.35% 18.00% 15.72%
Revenue per Share
54.86 50.68 48.77 47.45
Operating CF per Share
7.57 4.76 7.28 11.68
Capex per Share
(2.61) (1.46) (1.93) (2.17)
Free Cash Flow per Share
4.95 3.30 5.35 9.51
Cash per Share
11.91 11.11 10.54 11.46
Shareholders Equity per Share
(7.44) (7.07) (5.03) (4.22)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(7.44) (7.07) (5.03) (4.22)
Free Cash Flow
320.92 222.53 397.13 685.38
Working Capital
1,334.21 1,195.22 916.37 1,094.70
Capital Expenditures
(169.15) (98.30) (143.59) (156.15)
Net Current Asset Value
(14,001.83) (13,913.02) (13,795.83) (13,748.29)
EV/EBIT
11.50 9.74 8.87 9.30
Capex to Sales
0.05 0.03 0.04 0.05
Price to Operating Income
6.77 4.96 4.13 4.68
Other line items
Average Receivables
3,060.22 2,885.38 2,758.36 2,808.60
Average Payables
655.14 643.70 621.67 571.92
Average Inventory
148.92 146.07 147.59 134.05
Average Assets
17,601.23 17,309.20 17,382.69 17,529.82
Average Common Equity
(294.97) (241.45) 11.07 141.22

Fold the line items

Columns are period end dates